Ş. Targan - Concepedia

Author

Ş. Targan

Cedars-Sinai Medical Center

Also Known As

S R Targan, S Targan, S. Targan, S.R. Targan, SR Targan, SR. Targan, Ş. Targan

Publications

1.9K

Citations

H-Index

Concepts

All Affiliations

Cedars-Sinai Medical Center University of California, Los Angeles West Los Angeles College Mayo Clinic Wadsworth Center

ŞT

About

Ş. Targan is an author at Cedars-Sinai Medical Center specializing in medicine, immunology, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	12	448
2	Cell Biology	6	6	280
3	Gastroenterology	6	6	232
4	Allergy	1	1	36
5	Cellular Physiology	1	1	67

Ş. Targan

Publications

1.8K

Citations

H-Index

Page 1

	Year	Citations
A role for TNF-alpha and mucosal T helper-1 cytokines in the pathogenesis of Crohn’s disease SE Plevy, C J Landers, John Prehn, The Journal of Immunology	1997	387
Analysis of intestinal lymphocytes in mouse colitis mediated by transfer of CD4+, CD45RBhigh T cells to SCID recipients R. Aranda, Beate C. Sydora, P L McAllister, The Journal of Immunology	1997	318
Divergent induction of apoptosis and IL-8 secretion in HT-29 cells in response to TNF-α and ligation of Fas antigen Maria T. Abreu-Martin, Alda Vidrich, David H. Lynch, The Journal of Immunology	1995	243
Interferon activation of "pre-spontaneous killer" (pre-SK) cells and alteration in kinetics of lysis of both "pre-SK" and active SK cells. Ş. Targan, Fred Dorey The Journal of Immunology	1980	168
Perinuclear anti-neutrophil cytoplasmic antibodies are spontaneously produced by mucosal B cells of ulcerative colitis patients Ş. Targan, C J Landers, L Cobb, The Journal of Immunology	1995	114
Inhibition of a novel fibrogenic factor Tl1a reverses established colonic fibrosis David Q. Shih, Libo Zheng, Xiaoling Zhang, Mucosal Immunology InflammationFibrosisColonic FibrosisMucosal ImmunologyImmunology	2014	102
Nuclear localization of the antigen detected by ulcerative colitis-associated perinuclear antineutrophil cytoplasmic antibodies. P Billing, Salim Tahir, B. Calfin, PubMed	1995	67
Activation of human NKCC by moderate exercise: increased frequency of NK cells with enhanced capability of effector--target lytic interactions. Ş. Targan, L J Britvan, Fred Dorey PubMed ImmunotoxicologyImmunologyNk CellsCell DeathImmunologic Mechanism	1981	67
Is the NK lytic process involved in the mechanism of NK suppression of antibody-producing cells? Ş. Targan, J A Brieva, Walter Newman, The Journal of Immunology Autoimmune DiseaseAntibody-producing CellsLaboratory ImmunologyMedicineImmunotoxicology	1985	47
Phase II trial of extended dose anti-CTLA-4 antibody ipilimumab (formerly MDX-010) with a multi-peptide vaccine for resected stages IIIC and IV melanoma Jeffrey S. Weber, Ş. Targan, Ronald Scotland, Journal of Clinical Oncology ImmunodeficienciesImmunologyImmune RegulationImmunoeditingImmunotherapeutics	2006	39

Page 1